BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 25636452)

  • 1. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
    Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
    Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
    Li X; Wang F; Sun Y; Fan Q; Cui G
    Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis.
    Ye LC; Ren L; Qiu JJ; Zhu DX; Chen T; Chang WJ; Lv SX; Xu J
    Tumour Biol; 2015 Nov; 36(11):8747-54. PubMed ID: 26050227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
    Sun M; Xia R; Jin F; Xu T; Liu Z; De W; Liu X
    Tumour Biol; 2014 Feb; 35(2):1065-73. PubMed ID: 24006224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MEG3 regulates proliferation, apoptosis, and autophagy and is associated with prognosis in glioma.
    Zhao H; Wang X; Feng X; Li X; Pan L; Liu J; Wang F; Yuan Z; Yang L; Yu J; Su R; Zhang Y; Ma L
    J Neurooncol; 2018 Nov; 140(2):281-288. PubMed ID: 30284203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MEG3 acts a biomarker and regulates cell functions by targeting ADAR1 in colorectal cancer.
    Wang W; Xie Y; Chen F; Liu X; Zhong LL; Wang HQ; Li QC
    World J Gastroenterol; 2019 Aug; 25(29):3972-3984. PubMed ID: 31413531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.
    Zhang J; Yao T; Wang Y; Yu J; Liu Y; Lin Z
    Cancer Biol Ther; 2016; 17(1):104-13. PubMed ID: 26574780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
    Gao Y; Lu X
    Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression.
    Gong H; Wen H; Zhu X; Lian Y; Yang X; Qian Z; Zhu J
    Tumour Biol; 2017 Jun; 39(6):1010428317705336. PubMed ID: 28618933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased long noncoding RNA SNHG20 predicts poor prognosis in colorectal cancer.
    Li C; Zhou L; He J; Fang XQ; Zhu SW; Xiong MM
    BMC Cancer; 2016 Aug; 16():655. PubMed ID: 27543107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.
    Kong H; Wu Y; Zhu M; Zhai C; Qian J; Gao X; Wang S; Hou Y; Lu S; Zhu H
    Oncotarget; 2016 Aug; 7(31):50428-50436. PubMed ID: 27391432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ZEB1-AS1 expression predicts progression and poor prognosis of colorectal cancer.
    Fu J; Cui Y
    Int J Biol Markers; 2017 Oct; 32(4):e428-e433. PubMed ID: 28967064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated expression of SNHG6 predicts poor prognosis in colorectal cancer.
    Li M; Bian Z; Yao S; Zhang J; Jin G; Wang X; Yin Y; Huang Z
    Pathol Res Pract; 2018 May; 214(5):784-789. PubMed ID: 29506878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis.
    Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q
    Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer.
    Shen X; Bai Y; Luo B; Zhou X
    Biol Res; 2017 Oct; 50(1):32. PubMed ID: 28969673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer.
    Qiu JJ; Yan JB
    Tumour Biol; 2015 Sep; 36(9):7175-83. PubMed ID: 25894381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.